Stuver, R., Drill, E., Michaud, L., Casulo, C., Advani, R. H., Budde, E. L., Barr, P. M., Lee Batlevi, C., Caron, P. C., Constine, L. S., Drullinsky, P., Dandapani, S. V., Friedberg, J. W., Grieve, C., Hamlin, P. A., Hoppe, R., Horwitz, S. M., Khan, N., Joseph, A., Matasar, M. J., Noy, A., Palomba, M. L., Schöder, H., Sraus, D. J., Vemuri, S., Yahalom, J., Yang, J. C., Zelenetz, A. D., Moskowitz, C. H., Kumar, A. and Moskowitz, A. J. (2020) “Five-year results of short-course brentuximab vedotin combined with chemotherapy and radiation in early stage, unfavorable Hodgkin lymphoma”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.301587.